Aarhus University Hospital Skejby
|
|||||||||
2013-01-08: Symposium "Molecular Oncology - present achievements and future directions"
|
|||||||||
2012-12-20: MOMA's research in biomarkers in prostate cancer funded by The Danish National Advanced Technology Foundation
|
|||||||||
2012-09-27: Job vacancy A two-year post doc position in molecular prostate cancer research at MOMA is available. Application deadline: October, 7th 2012. |
|||||||||
2012-09-26: MOMA has received major funding
Project titel: "The cell community in bladder and colon cancer; studies in clinical specimens and an animal model for identification of metastatic and treatment resistant cell populations" |
|||||||||
2012-07-11: Job vacancy A three-year post doc position in cancer genomics in the bioinformatics group at MOMA is available. Application deadline: September, 3rd 2012. |
|||||||||
2012-04-26: Paper receives award
Fristrup N, Ulhøi BP, Birkenkamp-Demtröder K, Mansilla F, Sanchez-Carbayo M, Segersten U, Malmström PU, Hartmann A, Palou J, Alvarez-Múgica M, Zieger K, Borre M, Orntoft TF, Dyrskjøt L.
|
|||||||||
2011-12-29: Next Generation Sequencing Core Center Inauguration MOMA offers next generation sequencing services to users from hospitals and universities at our newly established core facility. MOMA NGS Core Center will hold an opening symposium for all interested parties on January, 12th 2012.
|
|||||||||
2011-12-20: Job vacancy A three-year postdoc position in molecular colorectal cancer research is available for application. Title: "Development of personalized tumor biomarkers for disease monitoring using massive paralleled sequencing." Application deadline: January, 18th 2012. |
|||||||||
2011-11-15: Job vacancy A three-year PhD position in bioinformatics with focus on prostate cancer is open for application. Title: "Development of integrative data analysis methods and data visualizations tools to identify clinically relevant molecular changes in prostate cancer: a systems biology approach"
|
|||||||||
2011-09-27: MolPros website launched
MolPros is a 4-year project (2011-2014) supported by a grant (~2 mil. Euros, 14.5 mil. DKK) from the Danish Council for Strategic Research and co-financed (~1 mil. Euros, 7 mil. DKK) by the involved partners. Read more at molpros.dk
|
|||||||||
2011-09-21: Prof. Torben Ørntoft novel elected Fellow of EACS
Fellows of the Academy will contribute to the preparation of position papers, interact with the EU institutions and the ECCO Policy Committee to facilitate proposals and help the implementation process of new policies in order to ensure that cancer research remains at the top of the European cancer health and research policy agenda. |
|||||||||
2011-06-23: Job vacancies MOMA has 2 vacant postdoc positions: Postdoc in molecular prostate cancer research (extended application deadline September, 12th 2011) Post doc in transcriptome-wide RNA structure analysis (application deadline August, 15th 2011)
|
|||||||||
2011-04-08: Blood screening method for colon cancer presented at AACR 102nd meeting Positive results in 4-year project partly funded by the "Danish National Advanced Technolgy Foundation" will be published by Exiqon A/S later this year. |
|||||||||
2011-04-05: PhD scholarship announcement A three-year PhD scholarship in Molecular Bladder Cancer Research is available. Read announcement (pdf) |
|||||||||
2011-03-03: MOMA in project "Systems Biology of Colorectal Cancer (SYSCOL)"
SYSCOL uses the tools of systems biology to develop a quantitative and comprehensive model of colorectal tumourigenesis. The model will include a wiring diagram that identifies cell-type specific and oncogenic pathways that contribute to colon tumourigenesis, and explains in molecular detail how a genotype of an individual CRC leads to activation of downstream genes that drive uncontrolled cell growth. Read more: |
|||||||||
2010-12-10: New genetic test to support early and precise diagnosis of prostate cancer MOMA will implement a large 4-year research project to reduce the unnecessary use of PSA-testing and overtreatment of prostate cancer among Danish patients. |
|||||||||
2010-10-05: Cell Line Authentication service available MOMA announces IdentiCell - a service to authenticate cell lines by STR-profiling.
For more details see flyer (pdf) or visit us at identicell.eu |
|||||||||
2010-06-25: Novel research will improve prostate cancer therapy
|
|||||||||
2010-06-03: The Danish National Advanced Technology Foundation supports two projects at MDL In 2010 the foundation invests 286 millions Danish kroner in 19 projects and platforms, the largest investement in the five years the foundation has existed. The two projects involve the scientific expertise of researchers at MDL to develop software to diagnose DNA-bases diseases and to use large numbers of archival formalin-fixed paraffine-embedded tissue samples on the next-generation sequencing platform for gene analysis. Press releases: CLC bio heading $2M project to develop molecular diagnostics solution
|
|||||||||
| 2010-05-05:
Fundings from The Danish Cancer Society 3 research projects at MDL have received fundings of 7.45 mill Danish kroner. The fundings run from 2011 to 2013 and support projects in bladder and prostate cancer. Out of 202 applications 56 projects have been funded with 74 mill Danish kroner by the scientific board of the Danish Cancer Society. The 3 projects at MDL are: Molecular changes in clinical bladder cancer. Identification of genetic and epigenetic biomarkers for prostate
cancer. Identification and characterization of circulating exosomes in
bladder cancer patients with focus on mRNA and non-coding RNA. |
|||||||||
2009-07-06: Vacant positions postdocs/assistant professor Several academic positions (full-time) as researcher in molecular clinical cancer research are available at MDL. Application deadline September, 6th 2009. Project descriptions for bladder and prostate cancer positions. |
|||||||||
2009-06-25: Vacant position administrator MDL offers a vacant position as an all-round research administrator, application deadline August 31, 2009. Read more (Danish). |
|||||||||
2009-06-24: MDL is granted a 19.5 million Danish Kroner appropriation
CMCC's research focuses on molecular classification of cancer patients at high risk of disease and identification of patients with the most agressive tumours. To achieve this, the newest molecular technologies and extensive biobanks are applied. Read more (Danish). |
|||||||||
2009-06-15: NormFinder software We are happy to note a frequent use of our NormFinder software and a high number of inquiries. Therefore, we have updated the NormFinder documentation (v19) and created a sample data set, which better illustrates the use of the NormFinder software. We hope to have answered frequently asked questions about group identifiers, data sheet organisation and evaluation of top ranked normalisation genes. If you need more help, please use the information on the NormFinder page. |
|||||||||
2009-05-31: MDL research on "Cancer Research" cover Associated professor Lars Dyrskjøt, who recently won a prize being "The most publishing researcher aged under 40 at Skejby Hospital", led the work on miRNAs in bladder cancer resulting in this publication:
Read more (in Danish). See coverage by regional TV (Danish). |
|||||||||
2009-01-27: MOMA opening The official opening of the novel Department of Molecular Medicine (MOMA) at Aarhus University Hospital Skejby takes place at March, 11th 2009. MDL will be hosting a two-day symposium "Molecular Oncology" mainly aimed at PhD students and Postdocs in molecular cancer research to celebrate the inauguration of MOMA at March 12-13th, 2009.
|
|||||||||
2008-11-19: MDL is moving
MDL is going to enjoy spacious and modern facilities, which make room for state-of-the-art equipment and provide stimulating working surroundings for the staff. New phone numbers from 16-12-2008: Laboratory +45 8949 9430 Read more about MOMA (Dept. of Molecular Medicine) in Danish |
|||||||||
2008-10-14: MDL's gentest for laktoseintolerans omtalt i Ugeskrift for Læger nr. 42
Mælkesukkerproblemer kan nu nemt bestemmes i en blodprøve » Diagnosticering
af laktoseintolerans hos voksne
|
|||||||||
2008-09-11: Speciale Studerende i KræftforskningHos Molekylær Diagnostisk Laboratorium, Klinisk Biokemisk
Afdeling, Skejby Sygehus arbejder vi med molekylær karakteristik
af blære-, prostata- og tarmkræft. Målet med forskningen
er at opnå en molekylær klassifikation af sygdommene
for dermed at kunne give en mere optimal behandling af patienterne.
Desuden er målet at opnå en større forståelse
af sygdommenes molekylære forhold i aktive pathways og i relation
til sygdomsforløb og behandlingsrespons. Du kan læse mere her Her |
|||||||||
|
|||||||||
2007-03-19: Updated Request Form The request form for diagnostic genetical analysises has been updated
to version 8, please download from |
|||||||||
2007-03-12: MDL 10-year anniversary On May, 1st 1997 MDL was officially founded. The 10-year anniversary will be celebrated on April, 27th. |
|||||||||
2007-02-26: Updated Request Form The request form for diagnostic genetical analysises has been updated,
please download from |
|||||||||
| 2007-02-21: Vacant positions MDL has three open postdoc positions (3-years) in Clinical Molecular Cancer Research. Applicants will be evaluated by a review committee at Aarhus University, The Faculty of Health Sciences. Read job announcements (Danish) Application deadline: March 19th, 2007 |
|||||||||
| 2006-12-04: Cells get old fighting cancer
International cooperation, led by the known researchers and spouses Jirina Bartkova and Jiri Bartek at The Danish Cancer Society, Copenhagen, and with Danish scientists from The Danish Cancer Society, MDL and Rigshospitalet resulted in another publication in the recognized journal Nature: Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas
D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC,
Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M,
Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday
T, Halazonetis TD, Bartek J, Gorgoulis VG. Read more (in Danish) at the The Danish Cancer Society website. |
|||||||||
| 2006-09-27: Vacant position for molecular biologist MDL seeks a molecular biologist full-time (37 h/week). Application deadline: 16th October 2006. Read more (Danish)... |
|||||||||
2006-07-27: New research results within colorectal cancer therapy MDL contributed to results published in Nature Genetics, that inflict the therapy of colorectal cancer with HDAC inhibitors. In the future, an individual test for a certain mutation can decide if HDAC-inhibition therapy is useful or not. Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz M, Palacios J, Arango D, Orntoft TF, Aaltonen LA, Schwartz S, Esteller M. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet. 2006 May;38(5):566-9. Epub 2006 Apr 16. PubMed |
|||||||||
| 2006-06-28: MDL seeks graduate student The prostate cancer group at MDL seeks a graduate student (molecular
biology) for a master thesis project from September, 1st 2006: |
|||||||||
| 2006-05-17: MDL offers a new genetic analysis A mutation screen for adult–type hypolactasia (LCT -13910C>T) is offered in MDL's panel of diagnostic services. Please refer to the Dep. of Clinical Biochemistry for further information. A new requisition form can be downloaded. |
|||||||||
| 2006-02-09:
MDL participates in ”The MicroRNA Research |
|||||||||
2006-01-24: MDL comments on breakthrough
in prostate cancer research |
|||||||||
| 2005-11-11: MDL passes
German External Quality Assessment scheme with full marks MDL participated in an External Quality Assessment (EQA) program for molecular diagnostics of HNPCC 2005 in Bonn and München, Germany. Participants included 12 German members of "Berufsverband Deutscher Humangenetiker e.V." and HNPCC centres supported by the German Cancer Aid as well as four laboratories from abroad. Nine laboratories including MDL achieved the maximum 18 points for mutational analysis by sequencing, MLPA and DHPLC, interpretation and written report to the counselling physician evaluating the results and diagnostics possibilities/recommendation for family members of the screened patient. |
|||||||||
2005-08-22: GEO data available
|
|||||||||
|
MDL's research is covered by an article in the latest issue of Århus University's alumne magazine "Augustus" (page 20, in Danish). |
|||||||||
| 2005-05-23: Prof. T. Ørntoft receives
award |
|||||||||
2005-04-14: Research results
from MDL on "Nature" cover |
|||||||||
| 2005-04-04: Request form for
genetic analysis To order genetic analysis service, please use this request form (in Danish). |
|||||||||
 2005-03-01:
Center for Molecular Cancer ResearchCMCC, a John and Birthe Meyer Cancer Center, will be officially opened at March, 3rd at the Science Park at Skejby Hospital. |
|||||||||
| 2005-02-01: NormFinder
software |
|||||||||
| 2004-11-02: Job announcements MDL has vacant positions in Clinical Molecular Cancer Research as researcher or group leader. Application deadline is by November, 19th, 2004. |
|||||||||
| 2004-08-23: NormFinder software NormFinder - a new MS Excel add-in for normalization of real-time quantitative RT-PCR data developed by MDL. |
|||||||||
2004-08-10: Symposium announcement The Third Symposium on Array Technology in Research and Diagnostics will be held from October, 29th to 30th, 2004 at the Aarhus University Hospital, Skejby. |
|||||||||
| 2004-06-22: MDL receives major funding MDL has received a major donation of The John and Birthe Meyer Foundation of 19.8 million Danish Kroner (about 2,6 mill. Euro) to strengthen and enhance its research in bladder, colon and prostate cancer. A new Center for Molecular Clinical Cancer Research will be founded at Aarhus University Hospital at Skejby in January 2005. MDL will cooperate with clinical and surgical departments from different hospitals as well as research laboratories at Aarhus University to gather and investigate numerous tumor samples. Read this in Danish |
|||||||||
A new way of diagnosing prostate cancer and its aggressiveness by biomarkers in eg. urine should lead to fewer prostatectomies.
The Danish Council for Independent Research funds an upcoming project using pig animal models with DKK 5.85 mill. (appr. 780,000 Euros).
The EAU Section of Oncological Urology (ESOU) congress 2012 in Hamburg has awarded our recent paper in Am J Pathol to the best published paper in Urologic Oncology.
The European Academy of Cancer Sciences has elected 25 new Fellows by online voting, bringing the number of members up to 164. Prof. Torben F. Ørntoft is the 5th member in Denmark - a life long distinction - specialising in Translational Molecular Research.
Professor Torben F. Ørntoft and associate professor Claus Lindbjerg Andersen lead MOMA's participation in the SYSCOL project funded under the EU 7th Framework Programme by 12 million Euros with participating research groups from 10 countries.
Today,
when a patient is diagnosed with prostate cancer for the clinicians
it can be difficult to predict the aggressiveness of the disease.
Genomic
profiling of microRNAs in bladder cancer: miR-129 is associated
with poor outcome and promotes cell death in vitro. 
In
december 2008 MDL will move to new locations at the Science Center
Skejby (former residence of the newspaper Århus Stifstidende)
nearby and belong to the new Department of Molecular Medicine (MOMA)
at the Århus University Hospital Skejby.
www.mdl.dk/rekvisition.pdf
The
"Consul Ernst Carlsen Honorary Award" of 60.000 Danish
Kroner for excellent cancer research and humanitarian achievements,
carried out by prof. Torben Ørntoft and his research group
at MDL, was given to prof. Torben Ørntoft at monday. The
award is granted by a committee consisting of representatives from
Danish Universities.
Updated:8 January, 2013
MOMA,
Aarhus University Hospital, Brendstrupgårdsvej 100, 8200
Aarhus N, Denmark
Phone +45 7845 5310| Fax +45 8678 2108 | email: contact@mdl.dk
| webmaster: webmaster@mdl.dk